Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Scabies on rise: Optimising treatment to avoid lack of response
Scabies on rise: Optimising treatment to avoid lack of response

Dermatologist Caroline Mahon provides updates on how to optimise topical permethrin treatment for scabies and how to use oral ivermectin in children
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Simonart T, Lam Hoai XL. Escalating threat of drug-resistant human scabies: Current insights and future directions. J Clin Med 2024;13(18):5511.
2. Ivens UI, Steinkjer B, Serup J, Tetens V. Ointment is evenly spread on the skin, in contrast to creams and solutions. Br J Dermatol 2001;145(2):264–67.
3. Rhodes LE, Diffey BL. Fluorescence spectroscopy: a rapid, noninvasive method for measurement of skin surface thickness of topical agents. Br J Dermatol 1997;136(1):12–17.
4. Gwee A, Steer A, Phongluxa K, et al. Ivermectin therapy for young children with scabies infection: a multicentre phase 2 non-randomized trial. Lancet Reg Health West Pac 2024;49:101144.
5. Jittamala P, Monteiro W, Smit MR, et al. A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication? PLoS Negl Trop Dis 2021;15(3):e0009144.
6. Levy M, Martin L, Bursztejn AC, et al. Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study. Br J Dermatol 2020;182(4):1003–06.